Go Pro

Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History

Oramed Pharmaceuticals logo
$4.66 -0.10 (-2.10%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.66 0.00 (-0.11%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oramed Pharmaceuticals Stock Price Performance

The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 93.36%, with a year-to-date return of 63.51%. In the past month, the stock has increased 9.13%, reflecting recent market activity.

As of the latest close, Oramed Pharmaceuticals traded at $4.66 with a market cap of $193.84 million and volume of 144,354 shares. Five years ago, the stock traded at $19.51, representing a 76.11% decrease over that period. At the time, it had a market cap of $634.35 million and a volume of 440,280 shares.

Receive ORMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-6.99%
1 Month
Performance
+9.13%
3 Month
Performance
+20.41%
Year-To-Date
Performance
+63.51%
1 Year
Performance
+93.36%
5 Year
Performance
-76.11%

ORMP Stock Chart for Saturday, September, 12, 2026

Oramed Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/11/2026$4.76$4.66
-2.10%
$4.82$4.65144,354 shs$193.84 million
09/10/2026$4.78$4.76
-0.42%
$4.85$4.66131,468 shs$198.02 million
09/09/2026$4.98$4.78
-4.02%
$4.94$4.70244,783 shs$198.85 million
09/08/2026$5.01$4.98
-0.60%
$5.01$4.92118,173 shs$207.15 million
09/07/2026$5.01$5.01$5.05$4.86226,863 shs$208.42 million
09/04/2026$4.93$5.01
+1.62%
$5.05$4.86226,863 shs$208.42 million
09/03/2026$5.07$4.93
-2.76%
$5.11$4.81187,973 shs$205.09 million
09/02/2026$4.85$5.07
+4.54%
$5.15$4.85188,602 shs$210.90 million
09/01/2026$5.02$4.85
-3.39%
$5.15$4.80255,326 shs$201.76 million
08/31/2026$5.03$5.02
-0.20%
$5.06$4.90242,840 shs$208.83 million
08/28/2026$5.10$5.03
-1.37%
$5.15$5.01154,132 shs$209.25 million
08/27/2026$5.34$5.10
-4.49%
$5.47$5.06276,319 shs$212.15 million
08/26/2026$5.21$5.34
+2.50%
$5.43$5.12400,528 shs$222.14 million
08/25/2026$4.82$5.21
+8.09%
$5.25$4.80641,452 shs$216.74 million
08/24/2026$4.81$4.82
+0.21%
$4.86$4.7490,738 shs$200.50 million
08/21/2026$4.79$4.81
+0.42%
$4.88$4.75126,129 shs$200.08 million
08/20/2026$4.79$4.79$4.86$4.68177,166 shs$199.26 million
08/19/2026$4.78$4.79
+0.21%
$4.94$4.70363,166 shs$199.26 million
08/18/2026$4.57$4.78
+4.60%
$4.82$4.48297,891 shs$198.83 million
08/17/2026$4.48$4.57
+2.01%
$4.60$4.44223,892 shs$190.11 million
08/14/2026$4.38$4.48
+2.28%
$4.53$4.30156,768 shs$186.37 million
08/13/2026$4.27$4.38
+2.58%
$4.45$4.30151,996 shs$182.21 million
08/12/2026$4.25$4.27
+0.47%
$4.47$4.22162,886 shs$177.62 million
08/11/2026$4.20$4.25
+1.19%
$4.35$4.16164,149 shs$176.80 million

This page (NASDAQ:ORMP) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners